TP53 and urinary bladder cancer: Subsequently, activated AKT blocks caspase activation and p21 cleavage induced by chemotherapy, eventually resulting in p53/p21 signaling activation and cell senescence, instead of apoptosis, in bladder cancer cells (Fig. 3A).